Sensex ends 142 points up, Nifty settles at 10790

Sensex ends 142 points up, Nifty settles at 10790
  • 1
    Share

Mumbai, Feb 21: Benchmark indices ended higher on Thursday led by gains in metals and pharma stocks.
The S&P BSE Sensex ended at 35,898, up 142 points or 0.4 per cent, while the broader Nifty50 index settled at 10,790, up 54 points or 0.5 per cent.
Among the sectoral indices, the Nifty Metal index ended 1.13 per cent higher led by gains in Welspun Corp and APL Apollo Tubes. The Nifty Pharma index, too, settled 1.16 per cent higher driven by Dr. Reddy’s Labs and Piramal Enterprises.
In the broader market, the S&P BSE MidCap index ended 123 points, or 0.88 per cent higher at 14,115, while S&P BSE SmallCap index settled at 13,414, up 148 points, or 1.07 per cent.
Buzzing stocks
Shares of Anil Dhirubhai Ambani Group (ADAG) companies have moved higher by 16 per cent in intra-day trade on Thursday, erasing most of their Wednesday’s losses on the BSE. The rally comes on the back of a Reliance Communications (RCom) statement where the company said that it is confident of paying entire Rs 550 crore and interest thereon with four weeks as directed by the Supreme Court (SC). Reliance Nippon Life Asset Management ended at Rs 187 apiece, up 20 per cent.
Shares of Tech Mahindra rose as much as 3.5 per cent in the intra-day trade on the BSE as the company’s board approved the buyback of 2.05 crore shares worth Rs 1,956 crore via tender route at Rs 950 per share. The board fixed March 6, 2019, as the record date. The stock settled at Rs 820.40 apiece, up 1.07 per cent.
Global markets
Buoyed by the Fed’s affirmation that it would be “patient” on interest rate rises, Asian shares were firm on Thursday. MSCI’s broadest index of Asia-Pacific shares outside Japan were steady in early trade, hovering just off their highest since early October.